Adecoagro S.a.NYSE: AGRO

Q2 Financial Statements

· MarketScreener
Adecoagro S.A. Condensed Consolidated Interim Financial Statements as of June 30, 2026 and for the six-month periods ended June 30, 2026 and 2025 Legal information Denomination: Adecoagro S.A. Legal address: 28, Boulevard Raiffeisen, L-2411, Luxembourg Company activity: Agricultural and agro-industrial Date of registration: June 11, 2010 Expiration of company charter: No term defined Number of register (RCS Luxembourg): B153.681 Issued Capital Stock: 147,872,161 common shares (Note 21) Outstanding Capital Stock: 144,307,966 common shares Treasury Shares: 3,564,195 common shares

Condensed Consolidated Interim Statements of Income

for the six-month and three-month periods ended June 30, 2026 and 2025

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

Six-months ended June 30, Three-months ended June 30,

Note 2026 2025 2026 2025

(unaudited)

Revenue

4

929,691

707,586

531,011

382,080

Cost of revenue

5

(664,594)

(594,582)

(363,716)

(318,346)

Initial recognition and changes in fair value of biological assets and agricultural produce

15

25,491

33,093

1,588

9,531

Changes in net realizable value of agricultural produce after harvest

2,764

2,560

5,902

1,337

Margin on manufacturing and agricultural activities before operating expenses

293,352

148,657

174,785

74,602

General and administrative expenses

6

(74,944)

(70,967)

(39,119)

(38,686)

Selling expenses

6

(111,763)

(76,752)

(58,785)

(39,606)

Other operating income, net

8

7,899

8,395

15,073

9,385

Profit from operations

114,544

9,333

91,954

5,695

Finance income

9

110,957

43,357

8,777

6,957

Finance costs

9

(105,764)

(47,648)

(59,546)

(22,674)

Other financial results - Net (loss) / gain of inflation effects on the monetary items

9

(13,195)

(5,317)

(6,521)

(5,727)

Financial results, net

9

(8,002)

(9,608)

(57,290)

(21,444)

Profit / (loss) before income tax

106,542

(275)

34,664

(15,749)

Income tax (expense) / benefit

10

(37,484)

1,939

(9,418)

(1,294)

Profit / (loss) for the period

69,058

1,664

25,246

(17,043)

Attributable to:

Equity holders of the parent

58,349

520

18,210

(17,558)

Non-controlling interest

10,709

1,144

7,036

515

Earnings per share attributable to the equity holders of the parent during the period:

Basic earnings/(loss) per share

0.406

0.005

0.125

(0.176)

Diluted earnings/(loss) per share

0.405

0.005

0.125

(0.175)

Condensed Consolidated Interim Statements of Comprehensive Income for the six-month and three-month periods ended June 30, 2026 and 2025

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

Six-months ended June 30, Three-months ended June 30, 2026 2025 2026 2025

(unaudited)

Profit / (Loss) for the period

69,058

1,664

25,246

(17,043)

Other comprehensive income:

Items that may be reclassified subsequently to profit or loss:

Exchange differences on translating foreign operations

125,297

30,409

(1,922)

(48,393)

Items that will not be reclassified to profit or loss:

Revaluation surplus net of tax

(65,976)

(1,075)

1,650

20,406

Other comprehensive income / (loss) for the period

59,321

29,334

(272)

(27,987)

Total comprehensive income / (loss) for the period

128,379

30,998

24,974

(45,030)

Attributable to:

Equity holders of the parent

116,823

29,836

17,902

(45,379)

Non-controlling interest

11,556

1,162

7,072

349

Condensed Consolidated Interim Statements of Financial Position as of June 30, 2026 and December 31, 2025

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

Note

June 30,

2026

December 31,

2025

(unaudited)

ASSETS

Non-Current Assets

Property, plant and equipment, net

11

3,086,174

3,010,351

Right of use assets

12

354,803

388,993

Investment property

13

24,037

24,037

Intangible assets, net

14

256,840

253,875

Biological assets

15

44,980

40,488

Deferred income tax assets

10

24,386

23,722

Trade and other receivables, net

17

89,353

82,889

Derivative financial instruments

16

2,855

1,888

Other Assets

3,625

3,459

Total Non-Current Assets

3,887,053

3,829,702

Current Assets

Biological assets

15

231,953

274,256

Inventories

18

426,404

306,271

Trade and other receivables, net

17

372,026

364,350

Derivative financial instruments

16

403

1,243

Short-term investments

28,044

89,826

Cash and cash equivalents

19

302,463

383,150

Total Current Assets

1,361,293

1,419,096

TOTAL ASSETS

5,248,346

5,248,798

SHAREHOLDERS EQUITY

Capital and reserves attributable to equity holders of the parent

Share capital

21

221,808

221,808

Share premium

21

841,643

876,091

Cumulative translation adjustment

(343,144)

(426,225)

Equity-settled compensation

13,953

11,358

Other reserves

150,753

153,237

Treasury shares

(5,344)

(7,940)

Revaluation surplus

251,102

275,709

Reserve from the sale of non-controlling interests in subsidiaries

41,574

41,574

Retained earnings

568,079

509,730

Equity attributable to equity holders of the parent

1,740,424

1,655,342

Non-controlling interest

138,156

136,949

TOTAL SHAREHOLDERS EQUITY

1,878,580

1,792,291

LIABILITIES

Non-Current Liabilities

Trade and other payables

23

719

700

Borrowings

24

1,577,679

1,379,921

Lease liabilities

25

260,665

296,643

Deferred income tax liabilities

10

716,067

728,634

Payroll and social security liabilities

26

821

567

Derivatives financial instruments

16

2,776

1,271

Provisions for other liabilities

27

23,507

22,269

Total Non-Current Liabilities

2,582,234

2,430,005

Current Liabilities

Trade and other payables

23

197,785

673,160

Current income tax liabilities

10

41,861

31,921

Payroll and social security liabilities

26

41,425

38,782

Borrowings

24

440,037

213,088

Lease liabilities

25

56,305

59,959

Derivative financial instruments

16

5,279

4,123

Provisions for other liabilities

27

4,840

5,469

Total Current Liabilities

787,532

1,026,502

TOTAL LIABILITIES

3,369,766

3,456,507

TOTAL SHAREHOLDERS EQUITY AND LIABILITIES

5,248,346

5,248,798

for the six-month periods ended June 30, 2026 and 2025

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

Attributable to equity holders of the parent

1,605

-

(1,605)

-

-

-

-

Granted

4,362

-

4,362

-

-

-

-

3,595

(19,496)

-

20,263

-

  • Employee share options (Note 22)

  • Restricted shares and restricted units (Note 22):

Vested

29,334

18

29,316

-

-

1,225

-

-

Balance at January 1, 2025 167,073 659,399 (413,757) 17,264 151,261 (16,989) 245,261 41,574 518,064 1,369,150 38,951 1,408,101

Other comprehensive income:

Revaluation of surplus (*) - - - - - - (1,545) - - (1,545) 470 (1,075)

Total comprehensive income for the period - - 28,091 - - - 1,225 - 520 29,836 1,162 30,998

Exercised - 52 - (15) - 8 - - - 45 - 45

Value of employee services - - - 13,454 - - - - - 13,454 - 13,454

Forfeited - - - - 2 (2) - - - - - -

-Purchase of own shares (Note 21) - (8,623) - - - (1,587) - - - (10,210) - (10,210)

Balance at June 30, 2025 (unaudited) 158,073 636,091 (385,666) 11,207 153,253 (7,965) 246,486 41,574 518,584 1,371,637 40,113 1,411,750

(35,000)

-

(35,000)

-

-

-

-

-

-

-

(35,000)

-

- Dividends to shareholders (Note 21)

-

-

-

-

-

-

Reserve from the sale of

Cumulative Translation Adjustment

Share Capital Share

(Note 21) Premium

30,409

(452)

30,861

-

-

2,770

-

-

-

28,091

-

Equity-settled Other Compensation reserves

Reduction of issued share capital of the company (Note 20):

(9,000)

-

-

-

-

9,000

-

-

-

-

-

-

-

-

28,091

-

-

- Items that will not be reclassified to profit or loss:

Other comprehensive income for the period

- Items that may be reclassified subsequently to profit or loss:

1,664

1,144

520

520

-

-

-

Exchange differences on translating foreign operations

-

-

-

-

Profit for the period

subsidiaries

Non- Total

Controlling Shareholders' Interest Equity

terests

Subtotal

Retained Earnings

non-

co ing

ntroll

in in

Treasury Revaluation

shares surplus

(*) Net of 417 of Income tax.

for the six-month periods ended June 30, 2026 and 2025 (continued)

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

Attributable to equity holders of the parent

Subtotal

Reserve

Share Capital (Note 21)

Share Premium

Cumulative Translation Adjustment

Equity-settled Compensati on

Other reserves

Treasury shares

Revaluation surplus

from the sale of non-controlling interests in subsidiaries

Retained Earnings

Non-Controlling Interest

Total Shareholder s' Equity

Balance at January 1, 2026 221,808 876,091 (426,225) 11,358 153,237 (7,940) 275,709 41,574 509,730 1,655,342 136,949 1,792,291

Profit for the period - - - - - - - 58,349 58,349 10,709 69,058

Other comprehensive income / (loss):

- Items that may be reclassified subsequently to profit or loss:

Exchange differences on translating foreign operations - - 83,081 - - - 36,409 - - 119,490 5,807 125,297

- Items that will not be reclassified to profit or loss:

Revaluation surplus (*) - - - - - - (61,016) - - (61,016) (4,960) (65,976)

Other comprehensive income for the period - - 83,081 - - - (24,607) - - 58,474 847 59,321

Total comprehensive income for the period - - 83,081 - - - (24,607) - 58,349 116,823 11,556 128,379

- Employee share options (Note 22):

Exercised

-

362

-

(116)

-

66

-

-

-

312

-

312

- Restricted shares and restricted units (Note 22):

Value of employee services

-

-

-

2,925

-

-

-

-

-

2,925

-

2,925

Vested

-

190

-

(214)

46

-

-

-

-

22

-

22

Granted

-

-

-

-

(2,530)

2,530

-

-

-

-

-

-

- Dividends to shareholders (Note 21)

-

(35,000)

-

-

-

-

-

-

-

(35,000)

-

(35,000)

- Dividends to non-controlling interest

-

-

-

-

-

-

-

-

-

-

(10,349)

(10,349)

Balance at June 30, 2026 (unaudited)

221,808

841,643

(343,144)

13,953

150,753

(5,344)

251,102

41,574

568,079

1,740,424

138,156

1,878,580

*) Net of 35,440 of Income tax.

(

for the six-month periods ended June 30, 2026 and 2025

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

Six-months ended June 30,

Note 2026 2025

(unaudited)

Cash flows from operating activities:

Profit for the period

69,058

1,664

Adjustments for:

Income tax expense / (benefit)

10

37,484

(1,939)

Depreciation of property, plant and equipment

11

137,360

81,752

Depreciation of right of use assets

12

39,263

38,372

Net loss from the fair value adjustment of investment properties

13

3,538

(479)

Amortization of intangible assets

14

2,206

1,075

Gain from disposal of other property items

8

(1,930)

(408)

Equity settled share-based compensation granted

7

4,154

11,894

Loss / (gain) from derivative financial instruments

8, 9

4,723

(7,193)

Interest, finance cost related to lease liabilities and other financial expense, net

9

76,000

39,787

Initial recognition and changes in fair value of non-harvested biological assets (unrealized)

(19,124)

(6,159)

Changes in net realizable value of agricultural produce after harvest (unrealized)

(880)

(2,137)

Provision and allowances

(407)

36

Tax credit recognized

8

(7,758)

(3,419)

Net loss of inflation effects on the monetary items

9

13,195

5,317

Foreign exchange gains, net

9

(91,082)

(34,000)

Subtotal

265,800

124,163

Changes in operating assets and liabilities:

Increase in trade and other receivables

(29,289)

(100,002)

Increase in inventories

(85,479)

(52,824)

Decrease in biological assets

91,978

113,599

Decrease in other assets

224

205

Decrease / (increase) in derivative financial instruments

5

(1,843)

(Decrease) / increase in trade and other payables

(99,144)

28,343

Increase in payroll and social security liabilities

1,774

1,101

Increase in provisions for other liabilities

1,057

90

Net cash provided by operating activities before taxes paid

146,926

112,832

Income tax paid

(24,554)

(1,795)

Net cash provided by operating activities

(a)

122,372

111,037

for the six-month periods ended June 30, 2026 and 2025 (continued)

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

Six-months ended June 30,

Note 2026 2025

(unaudited)

Cash flows from investing activities:

Acquisition of a business, net of cash and cash equivalents acquired

(401,832)

-

Purchases of property, plant and equipment

11

(141,510)

(137,681)

Purchases of cattle and non-current biological assets

(27)

(2,542)

Purchases of intangible assets

14

(723)

(818)

Interest received and others

16,354

4,000

Proceeds from sale of property, plant and equipment

1,998

615

Proceeds from sale of farmlands and other assets

-

1,601

Acquisition of short-term investment

16 (b)

(104,750)

(72,767)

Disposal of short-term investment

16

179,250

84,868

Net cash used in investing activities

(c)

(451,240)

(122,724)

Cash flows from financing activities:

Proceeds from equity settled share-based compensation exercise

312

45

Proceeds from long-term borrowings

24

367,278

27,547

Payments of long-term borrowings

(49,296)

(42,602)

Proceeds from short-term borrowings

147,964

166,725

Payment of short-term borrowings

(82,690)

(64,153)

(Payments) / proceeds of derivative financial instruments

(423)

33

Lease payments

(58,191)

(60,285)

Interest paid

(d)

(49,645)

(26,520)

Purchase of own shares

-

(10,210)

Dividends paid to non-controlling interest

(10,155)

-

Dividends to shareholders

21

(17,500)

(17,500)

Net cash generated in financing activities

(e)

247,654

(26,920)

Net decrease in cash and cash equivalents

(81,214)

(38,607)

Cash and cash equivalents at beginning of period

19

383,150

211,244

Effect of exchange rate changes and inflation on cash and cash equivalents

(f)

527

7,970

Cash and cash equivalents at end of period

19

302,463

180,607

Combined effect of IAS 29 and IAS 21 of the Argentine subsidiaries over:

2026

2025

Operating activities

(a)

(7,075)

2,228

Acquisition of short term investment

(b)

10,278

(444)

Investing activities

(c)

9,779

758

Interest paid

(d)

164

(2,338)

Financing activities

(e)

(530)

(4,654)

Exchange rate changes and inflation on cash and cash equivalents

(f)

(2,174)

1,668

For non-cash transactions, see Note 11 and 12 for property, plant and equipment and right of use assets, respectively.

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. General information

    Adecoagro S.A. (the "Company" or "Adecoagro") is the Group's ultimate parent company and is a société anonyme (stock corporation) organized under the laws of the Grand Duchy of Luxembourg. Adecoagro is a holding company primarily engaged through its operating subsidiaries in agricultural and agro-industrial activities. The Company and its operating subsidiaries are collectively referred to hereinafter as the "Group." The Group's activities are carried out through three major lines of business, namely, Sugar, Ethanol and Energy, Fertilizers and Food and Agriculture.

    As further described in Note 20, on December 18, 2025, the Group completed the acquisition of Profertil S.A. Accordingly, Profertil S.A. has been consolidated from the acquisition date. The condensed consolidated statement of income for the three and six-month periods ended June 30, 2026 and the condensed consolidated statement of cash flows for the six-month period ended June 30, 2026 include Profertil S.A. for the full interim period, while the comparative information for the six-month period ended June 30, 2025 does not include Profertil S.A. As a result, the condensed consolidated statement of income for three and six-month periods ended June 30, 2026 and the condensed consolidated statement of cash flows for the six-month period ended June 30, 2026 are not directly comparable with the corresponding 2025 periods. These condensed consolidated interim financial statements should be read in light of these circumstances and the related disclosure in Note 20.

    Adecoagro is a public company listed in the New York Stock Exchange (NYSE) as a foreign registered company under the ticker symbol of AGRO.

    These Interim Financial Statements have been approved for issue by the Board of Directors on August 7, 2026.

  2. Financial risk management

Risk management principles and processes

The Group is exposed to several risks arising from financial instruments including price risk, exchange rate risk, interest rate risk, liquidity risk and credit risk. A thorough explanation of the Group's risks and the Group's approach to the identification, assessment and mitigation of risks is included in the annual consolidated financial statements. There have been no significant changes to the Group's exposure and risk management principles and processes since December 31, 2025. See Note 2 to the annual consolidated financial statements for more information.

However, the Group considers that the following tables below provide useful information to understand the Group's interim results for the six-month period ended June 30, 2026. These disclosures do not appear in any particular order of potential materiality or probability of occurrence.

Argentina status:

The Argentine subsidiaries of the Group operate in an economic context in which main variables have a strong volatility as a consequence of political and economic uncertainties, both in national and international environments. Argentina's inflation rate for the six-month period ended June 30, 2026 and 2025 were 16.8% and 15.1%, respectively. The Group uses Argentina's official exchange rate to account for transactions in Argentina, mainly affecting the food and agricultural business segment, which as of June 30, 2026 and 2025, respectively, was 1,482 and 1,205, respectively, against the U.S. dollar.

On December 10, 2023, a new government took office with the aim to boost a deregulation of the Argentine economy and other regulations. Certain regulations and/or restrictions have been eased and others remain in force, although it is expected that they will be lifted gradually. However, the scope and timing of the measures, including but not limited to the existing foreign exchange regulations, remains uncertain as of the date of these Consolidated Financial Statements.

The Argentine Central Bank, under the prior administration, had implemented certain measures that controlled and restricted the ability of companies and individuals to access the foreign exchange market known as MULC (for its acronym in Spanish) for certain transactions. However, the performance of blue-chip swap transactions known as "Contado con Liquidación" or CCL (for its acronym in Spanish) was an alternative lawful mechanism. The blue-chip swap transactions are capital markets

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Financial risk management (continued)

    transactions that could be implemented in different ways, both for the inflow and outflow of funds. The implicit exchange rate applicable to this type of transactions is higher with respect to the official foreign exchange rate.

    Through Central Bank Communication "A" 8226 and Decree 269/2025, implemented in April 2025, Argentina introduced certain measures aimed at liberalizing its foreign exchange market. These measures included allowing individuals to purchase U.S. dollars for savings purposes without prior authorization, provided that transactions are made through bank debit, enabling the repatriation of dividends related to financial statements from 2025 onwards, and allowing payments for services to unrelated foreign parties to be made immediately, with a reduced 90-day waiting period for related parties.

    However, as of July 31, 2026, the complete removal of exchange controls has not yet materialized and several restrictions remain in force. The monetary policy framework has shifted to a managed floating exchange rate regime, under which the exchange rate bands are adjusted by the Central Bank based on recent monthly inflation data published by INDEC, rather than being expanded by a fixed 1% monthly rate. Despite the initial flexibilizations, legal entities remain prohibited from purchasing foreign currency for hoarding purposes. In addition, mandatory settlement requirements for foreign trade revenues within specific timeframes remain applicable, cross-restrictions continue to limit access to the official foreign exchange market for those operating in financial exchange markets such as MEP or CCL, and payments of financial debt between local subsidiaries and their foreign parent companies continue to be subject to limitations.

    • Exchange rate risk

The following tables show the Group's net monetary position broken down by various currencies for each functional currency in which the Group operates at June 30, 2026. All amounts are shown in US dollars.

June 30, 2026

(unaudited)

Functional currency

Peso

Net monetary position (Liability)/ Asset Argentine

Brazilian Reais

US Dollar Total

Argentine Peso

81,633

-

20,669

102,302

Brazilian Reais

(1,769)

(624,142)

-

(625,911)

US Dollar

(847,461)

(318,111)

(231,698)

(1,397,270)

Uruguayan Peso

-

-

(5,089)

(5,089)

Euro

-

-

(26,022)

(26,022)

Total

(767,597)

(942,253)

(242,140)

(1,951,990)

The Group's analysis shown on the tables below is carried out based on the exposure of each functional currency subsidiary against the U.S. Dollar. The Group estimated that, other factors being constant, a hypothetical 10% appreciation/ (depreciation) of the U.S. Dollar against the Brazilian real respective functional currencies for the period ended June 30, 2026 or the Uruguayan peso, or a 25% appreciation/(depreciation) of the U.S. Dollar against the Argentine peso.

June 30, 2026

(unaudited)

Functional currency

Peso

Net monetary position Argentine

Brazilian Reais

Chilean Peso

Total

US Dollar

(211,865)

(31,811)

200

(243,476)

(Decrease) or increase in Profit before income tax

(211,865)

(31,811)

200

(243,476)

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Financial risk management (continued)

    • Interest rate risk

      The following table shows a breakdown of the Group's fixed-rate and floating-rate borrowings per currency denomination and functional currency of the subsidiary issuing the loans at June 30, 2026 (all amounts are shown in US dollars):

      June 30, 2026

      (unaudited)

      Functional currency

      Peso

      Rate per currency denomination Argentine

      Brazilian Reais

      US

      Dollar

      Total

      Fixed rate:

      Brazilian Reais

      -

      131,042

      -

      131,042

      US Dollar

      214,228

      339,073

      1,081,605

      1,634,906

      Subtotal fixed-rate borrowings

      214,228

      470,115

      1,081,605

      1,765,948

      Variable rate:

      Brazilian Reais

      -

      223,215

      -

      223,215

      Euro

      -

      -

      28,553

      28,553

      Subtotal variable-rate borrowings

      -

      223,215

      28,553

      251,768

      Total borrowings as per analysis

      214,228

      693,330

      1,110,158

      2,017,716

      At June 30, 2026, if interest rates on floating-rate borrowings had been 1% higher (or lower) with all other variables held constant, Profit before income tax for the period would decrease as follows:

      June 30, 2026

      (unaudited)

      Functional currency

      Reais

      Rate per currency denomination Brazilian US Dollar Total

      Variable rate:

      Brazilian Reais

      (2,232)

      -

      (2,232)

      Euro

      -

      (286)

      (286)

      Decrease in profit before income tax (2,232) (286) (2,518)

    • Credit risk

      As of June 30, 2026, six banks accounted for approximately 70% of the total cash deposited (Credit Agricole, Itau, Rabobank, Santander, Max Capital and Banco do brasil).

    • Derivative financial instruments

      The following table shows the outstanding positions for each type of derivative contract as of June 30, 2026:

      Notes to the Condensed Consolidated Interim Financial Statements

      (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

      1. Financial risk management (continued)

        • Futures / Options

          June 30, 2026

          Type of

          derivative contract

          Quantities (thousands) (**)

          Notional

          amount

          Market

          Value Asset/

          Profit / (Loss)

          (*)

          (unaudited)

          (unaudited)

          Futures:

          Sale

          Soybean

          3

          1,021

          30

          30

          Sugar

          26

          9,785

          369

          (1,263)

          Options:

          Buy put

          Sugar

          24

          75

          75

          (682)

          Sell call

          Sugar

          69

          (99)

          (99)

          (1,365)

          Total

          122

          10,782

          375

          (3,280)

          (Liability)

          (*) Included in line "Gain / (Loss) from commodity derivative financial instruments" Note 8. (**) All quantities expressed in tons except otherwise indicated.

          Commodity future contract fair values are computed with reference to quoted market prices on future exchanges.

          • Other derivative financial instruments

            Floating-to-fixed interest rate swaps

            The Group's subsidiary Adecoagro Vale do Ivinhema entered into interest rate swap operations:

            1. In December 2020, with Itaú BBA in an aggregate amount of R$ 400 million. In these operations the company receives IPCA (Extended National Consumer Price Index) plus 4.24% per year, and pays CDI (an interbank floating interest rate in Reais) plus 1.85% per year. This swap was early terminated in December, 2025 and the subsidiary entered into a new interest rate swap operation with Itaú BBA in an aggregate amount of R$ 365 million. In this transaction, Adecoagro Vale do Ivinhema receives a fixed rate of 13.47% per annum and pays CDI (a floating interbank interest rate in Brazilian Reais) plus 0.05% per annum. This swap expires semiannually until December, 2034.

            2. In July 2024 with:

          • Itaú BBA in an aggregate amount of R$ 76 million. In this operation the company receives IPCA (Extended National Consumer Price Index) plus 6.80% per year and pays CDI (an interbank floating interest rate in Reais) plus 0.49% per year. This swap expires in July 2034.

            - BR Partners in an aggregate amount of R$ 115 million. In this operation the company receives IPCA (Extended National Consumer Price Index) plus 6.76% per year and pays CDI (an interbank floating interest rate in Reais) plus 0.41% per year. This swap expires in July 2031.

          • XP Investimentos in an aggregate amount of R$ 209 million. In this operation the Company receives pre-fixed rate 12.61% per year and pays CDI (an interbank floating interest rate in Reais) plus 0.48% per year. This swap expires in July 2031.

          These interest rate swap agreements resulted in a recognition of a loss of US$ 4.2 million for the six-month period ended June 30, 2026.

          Notes to the Condensed Consolidated Interim Financial Statements

          (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

          1. Financial risk management (continued)

            • Currency forward

              No significant currency forward is in place.

          2. Segment information

          We are an agro-industrial company in South America, with operations in Argentina, Brazil and Uruguay. Our businesses encompass agricultural production, industrial processing and the production of critical agricultural inputs. In agriculture, we produce a diversified portfolio of products-including various crops, rice, sugarcane and dairy-supplying both our own industrial operations and third-party clients. Our manufacturing activities include the processing and commercialization of value-added products, such as sugar, ethanol, energy, processed peanuts, rice and dairy products, like UHT milk and powdered milk, among others. In addition, we produce nitrogen-based fertilizers, supporting agricultural productivity in Argentina and South America. We also provide ancillary services such as grain warehousing, conditioning, handling and drying. Furthermore, we opportunistically conduct land sales and/or acquisitions.

          According to IFRS 8, operating segments are identified based on the 'management approach'. Operating segments are components of an entity about which separate financial information is available that is evaluated regularly by the chief operating decision maker ("CODM") in deciding how to allocate resources and in assessing performance. Our CODM is the Management Committee. IFRS 8 stipulates external segment reporting based on our internal organizational and management structure and on internal financial reporting to the chief operating decision maker.

          Following the completion of the acquisition of Profertil S.A. on December 18, 2025 (see Note 20), and effective January 1, 2026, the Group's chief operating decision maker reassessed the Group's internal reporting structure and the manner in which operating performance is reviewed and resources are allocated. This reassessment resulted in the identification of a new Fertilizers segment, which comprises primarily the manufacturing and commercialization of nitrogen-based fertilizers.

          In addition, effective January 1, 2026, we revised our segment reporting to reflect changes in the way we review operating performance and evaluate our business. As a result, our former farming activities are now presented as a single Food and Agriculture segment. The Food and Agriculture segment reflects an integrated business focused on the production and sale of food in various forms, including both raw agricultural outputs and manufactured food products. The Food and Agriculture segment includes the agricultural and related food activities that were previously managed and presented through separate verticals, including crops, rice and dairy. Beginning January 1, 2026, these activities are managed as one integrated value chain and evaluated based on overall segment operating performance. Accordingly, we evaluate results, make resource allocation decisions and assess profitability for the Food and Agriculture segment as a whole rather than based on separate operating results for the historical crops, rice or dairy verticals.

          Consequently, comparative information has been recasted in the six-month period ended June 30, 2026, to conform the current presentation. Profertil has been consolidated since the acquisition date. Accordingly, the Group's consolidated statement of income for the six-month period ended June 30, 2026 includes Profertil's results of operations for the full interim period, while the consolidated statement of income for the six-month period ended June 30, 2025 does not include Profertil's results of operations. The Group reports the results of operations of the acquired business in the Fertilizers segment. Accordingly, the consolidated financial statements should be read in light of these circumstances.

          Based on the foregoing, we operate in three reportable segments, namely, "Sugar, Ethanol and Energy", "Fertilizers" and , "Food and Agriculture".

          • 'Sugar, Ethanol and Energy' segment which consists of cultivating sugarcane which is processed in owned sugar mills, transformed into ethanol, sugar and electricity and then marketed;

      2. Segment information (continued)

      • The 'Fertilizers' segment consists of the production of nitrogen-based fertilizers, primarily urea, at our own industrial facility in Argentina, together with the commercialization of these products through a network of storage facilities spread across the country;

      • The 'Food and Agriculture' segment encompasses the Group's integrated agricultural operations, managed centrally as a single operating segment to maximize the overall use of land and resources. The segment's primary production activities consist of the planting, harvesting, and sale of crops-such as grains, oilseeds, and fibers (including soybeans, corn, wheat, peanuts, cotton, and sunflowers)-alongside the genetic development of seeds and cultivation of rice, and the production of raw milk in our own free-stalls. Following this primary phase, the segment's industrialization and service activities include the processing and commercialization of rice and other value-added products, the manufacturing of industrialized dairy goods (such as fluid milk, cheese, and powdered milk) within our own industrial facilities, and the provision of grain warehousing, conditioning, and drying services to third parties.

      As further discussed in Note 32 to our consolidated financial statements for the year ended December 31, 2025, we apply IAS 29 to our operations in Argentina for those subsidiaries with the peso as its functional currency. According to IAS 29, all Argentine Peso-denominated non-monetary items in the statement of financial position are adjusted by applying a general price index from the date they were initially recognized to the end of the reporting period. Likewise, all Argentine Peso-denominated items in the statement of income are expressed in terms of the measuring unit current at the end of the reporting period, consequently, income statement items are adjusted by applying a general price index on a monthly basis from the dates they were initially recognized in the financial statements to the end of the reporting period. This process is called "re-measurement". Once the re-measurement process is completed, all Argentine Peso denominated accounts are translated into U.S. Dollars, which is our reporting currency, applying the guidelines in IAS 21 "The Effects of Changes in Foreign Exchange Rates" ("IAS 21"). IAS 21 requires that amounts be translated at the closing rate at the date of the most recent statement of financial position. This process is called "translation". The re-measurement and translation processes are applied on a monthly basis until year-end. Due to these processes, the re-measured and translated results of operations for a given month are subject to change until year-end, affecting comparison and analysis.

      However, the internal reporting reviewed by the CODM departs from the application of IAS 29 and IAS 21 re-measurement and translation processes discussed above. For segment reporting purposes, the segment results of Argentine subsidiaries with the peso as its functional currency for each reporting period were adjusted for inflation and translated into the reporting currency using the reporting period average exchange rate. The translated amounts were not subsequently re-measured and translated in accordance with the IAS 29 and IAS 21 guidelines. In order to evaluate the segment's performance, results of operations in Argentina are based on monthly data adjusted for inflation and converted into the monthly US dollar average exchange rate. These converted amounts are not subsequently readjusted and reconverted as described under IAS 29 and IAS 21. It should be noted that this translation methodology for evaluating segment information is the same that the Group uses to translate results of operations from its other subsidiaries from other countries that have not been designated hyperinflationary economies because it allows for a more accurate analysis of the economic performance of its business as a whole. The CODM believes that the exclusion of the re-measurement and translation processes from the segment reporting structure allows for a more useful presentation and facilitates period-to-period comparison and performance analysis.

      For all the Group's segments, the primary operating performance measure is "Profit or Loss from Operations" measured in accordance with the procedure outlined above. Total segment assets and liabilities are measured in a manner consistent with that of the Consolidated Financial Statements. These assets and liabilities are allocated based on the operations of the segment and the physical location of the asset.

      The following tables show a reconciliation of the reportable segments information reviewed by our CODM with the reportable segment information measured in accordance with IAS 29 and IAS 21 as per the Consolidated Financial Statements for all periods presented. These tables do not include information for the Sugar, Ethanol and Energy nor Fertilizer reportable segments since this information is not affected by the application of IAS 29 and therefore there is no difference between the information reviewed by our CODM and the information included in the Consolidated Financial Statements:

  2. Segment information (continued)

Segment reconciliation for the six-month period ended:

June 30, 2026 (unaudited) Food and Agriculture Corporate Total

Total segment reporting

Adjustment

Total as per statement of income

Total segment reporting

Adjustment

Total as per statement of income

Total segment reporting

Adjustment

Total as per statement of income

Revenue

375,729

1,460

377,189

-

-

-

928,231

1,460

929,691

Cost of revenue

(343,216)

(1,562)

(344,778)

-

-

-

(663,032)

(1,562)

(664,594)

Initial recognition and changes in fair value of biological assets and agricultural produce

33,260

163

33,423

-

-

-

25,328

163

25,491

Changes in net realizable value of agricultural produce after harvest

2,297

(169)

2,128

-

-

-

2,933

(169)

2,764

Margin on manufacturing and agricultural activities before operating expenses

68,070

(108)

67,962

-

-

-

293,460

(108)

293,352

General and administrative expenses

(31,105)

(139)

(31,244)

(16,216)

(234)

(16,450)

(74,571)

(373)

(74,944)

Selling expenses

(52,945)

(432)

(53,377)

(210)

(2)

(212)

(111,329)

(434)

(111,763)

Other operating (expense) / income, net

(2,203)

(215)

(2,418)

136

(7)

129

8,121

(222)

7,899

Profit / (loss) from operations

(18,183)

(894)

(19,077)

(16,290)

(243)

(16,533)

115,681

(1,137)

114,544

Depreciation of Property, plant and equipment and amortization of Intangible assets

(21,041)

(260)

(21,301)

(817)

(12)

(829)

(139,294)

(272)

(139,566)

Net gain from Fair value adjustment of Investment property

(3,369)

(169)

(3,538)

-

-

-

(3,369)

(169)

(3,538)

Segment reconciliation for the six-month period ended:

June 30,2025 (unaudited) Food and Agriculture Corporate Total

Total segment reporting

Adjustment

Total as per statement of income

Total segment reporting

Adjustment

Total as per statement of income

Total segment reporting

Adjustment

Total as per statement of income

Revenue

399,242

(8,047)

391,195

-

-

-

715,633

(8,047)

707,586

Cost of revenue

(353,617)

7,427

(346,190)

-

-

-

(602,009)

7,427

(594,582)

Initial recognition and changes in fair value of biological assets and agricultural produce

25,526

(1,145)

24,381

-

-

-

34,238

(1,145)

33,093

Changes in net realizable value of agricultural produce after harvest

3,498

(164)

3,334

-

-

-

2,724

(164)

2,560

Margin on manufacturing and agricultural activities before operating expenses

74,649

(1,929)

72,720

-

-

-

150,586

(1,929)

148,657

General and administrative expenses

(31,254)

1,041

(30,213)

(24,957)

620

(24,337)

(72,628)

1,661

(70,967)

Selling expenses

(46,012)

1,289

(44,723)

(136)

6

(130)

(78,047)

1,295

(76,752)

Other operating (expense) / income, net

2,699

(38)

2,661

(143)

5

(138)

8,428

(33)

8,395

Profit / (loss) from operations

82

363

445

(25,236)

631

(24,605)

8,339

994

9,333

Depreciation of Property, plant and equipment and amortization of Intangible assets

(18,125)

596

(17,529)

(870)

30

(840)

(83,453)

626

(82,827)

Net loss from Fair value adjustment of Investment property

479

-

479

-

-

-

479

-

479

3. Segment information (continued)

Fertilizers

Segment analysis for the six-month period ended June 30, 2026 (unaudited)

Sugar, Ethanol and Energy

Food and Agriculture

Corporate Total

Revenue

256,729

295,773

375,729

-

928,231

Cost of revenue

(192,584)

(127,232)

(343,216)

-

(663,032)

Initial recognition and changes in fair value of biological assets and agricultural produce

(7,932)

-

33,260

-

25,328

Changes in net realizable value of agricultural produce after harvest

636

-

2,297

-

2,933

Margin on manufacturing and agricultural activities before operating expenses

56,849

168,541

68,070

-

293,460

General and administrative expenses

(14,569)

(12,681)

(31,105)

(16,216)

(74,571)

Selling expenses

(32,980)

(25,194)

(52,945)

(210)

(111,329)

Other operating (expense) / income, net

3,993

6,195

(2,203)

136

8,121

Profit / (loss) from operations

13,293

136,861

(18,183)

(16,290)

115,681

Depreciation of Property, plant and equipment and amortization of Intangible assets

(80,535)

(36,901)

(21,041)

(817)

(139,294)

Net gain from Fair value adjustment of Investment property

-

-

(3,369)

-

(3,369)

Initial recognition and changes in fair value of biological assets and agricultural produce (unrealized)

11,441

-

7,275

-

18,716

Initial recognition and changes in fair value of biological assets and agricultural produce (realized)

(19,373)

-

25,985

-

6,612

Changes in net realizable value of agricultural produce after harvest (unrealized)

-

-

880

-

880

Changes in net realizable value of agricultural produce after harvest (realized)

636

-

1,417

-

2,053

As of June 30, 2026:

Farmlands and farmland improvements, net

89,249

-

642,130

-

731,379

Machinery, equipment, building and facilities, and other fixed assets, net

264,641

1,183,678

289,941

-

1,738,260

Bearer plants, net

455,911

-

1,382

-

457,293

Work in progress

43,925

87,285

28,032

-

159,242

Right of use asset

320,291

10,238

24,170

104

354,803

Investment property

-

-

24,037

-

24,037

Goodwill

4,219

208,204

17,892

-

230,315

Biological assets

149,106

-

127,827

-

276,933

Finished goods

60,874

85,441

85,861

-

232,176

Raw materials, Stocks held by third parties and others

31,127

6,078

157,023

-

194,228

Total segment assets

1,419,343 1,580,924

1,398,295 104

4,398,666

Borrowings

647,356

985,218

385,142

-

2,017,716

Lease liabilities

285,584

11,075

20,174

137

316,970

Total segment liabilities

932,940 996,293

405,316 137

2,334,686

  1. Segment information (continued)

    Fertilizers

    Segment analysis for the six-month period ended June 30, 2025 (unaudited)

    Sugar, Ethanol and Energy

    Food and Agriculture

    Corporate Total

    Revenue

    316,391

    -

    399,242

    -

    715,633

    Cost of revenue

    (248,392)

    -

    (353,617)

    -

    (602,009)

    Initial recognition and changes in fair value of biological assets and agricultural produce

    8,712

    -

    25,526

    -

    34,238

    Changes in net realizable value of agricultural produce after harvest

    (774)

    -

    3,498

    -

    2,724

    Margin on manufacturing and agricultural activities before operating expenses

    75,937

    -

    74,649

    -

    150,586

    General and administrative expenses

    (16,417)

    -

    (31,254)

    (24,957)

    (72,628)

    Selling expenses

    (31,899)

    -

    (46,012)

    (136)

    (78,047)

    Other operating (expense) / income, net

    5,872

    -

    2,699

    (143)

    8,428

    Profit / (loss) from operations

    33,493

    -

    82

    (25,236)

    8,339

    Depreciation of Property, plant and equipment and amortization of Intangible assets

    (64,458)

    -

    (18,125)

    (870)

    (83,453)

    Net loss from Fair value adjustment of Investment property

    -

    -

    479

    -

    479

    Initial recognition and changes in fair value of biological assets and agricultural produce (unrealized)

    3,962

    -

    (102)

    -

    3,860

    Initial recognition and changes in fair value of biological assets and agricultural produce (realized)

    4,750

    -

    25,628

    -

    30,378

    Changes in net realizable value of agricultural produce after harvest (unrealized)

    -

    -

    2,137

    -

    2,137

    Changes in net realizable value of agricultural produce after harvest (realized)

    (774)

    -

    1,361

    -

    587

    As of December 31, 2025:

    Farmlands and farmland improvements, net

    88,896

    -

    651,663

    -

    740,559

    Machinery, equipment, building and facilities, and other fixed assets, net

    245,119

    1,218,881

    254,611

    -

    1,718,611

    Bearer plants, net

    413,604

    -

    1,232

    -

    414,836

    Work in progress

    25,622

    83,717

    27,006

    -

    136,345

    Right of use assets

    352,466

    9,208

    26,788

    531

    388,993

    Investment property

    -

    -

    24,037

    -

    24,037

    Goodwill

    3,969

    208,204

    15,597

    -

    227,770

    Biological assets

    127,347

    -

    187,397

    -

    314,744

    Finished goods

    61,457

    33,416

    75,372

    -

    170,245

    Raw materials, Stocks held by third parties and others

    24,120

    5,983

    105,923

    -

    136,026

    Total segment assets

    1,342,600 1,559,409

    1,369,626

    531

    4,272,166

    Borrowings

    570,737

    711,099

    205,771

    105,402

    1,593,009

    Lease liabilities

    324,888

    9,895

    21,118

    701

    356,602

    Total segment liabilities

    895,625 720,994

    226,889

    106,103

    1,949,611

  2. Revenue

The following tables show our various sources of revenue for the periods indicated:

Six-months ended June 30,

2026

2025

(unaudited)

Revenue of manufactured products and services rendered:

Ethanol

171,394

165,647

Sugar

52,396

126,730

Energy (*)

18,737

14,539

Urea

250,301

-

Ammonia

22,455

-

Peanut (*)

25,297

32,387

Sunflower

5,114

2,924

Cotton

38

2,339

Rice

94,786

116,107

Fluid milk (UHT)

68,935

59,249

Powder milk

24,530

20,815

Other dairy products

40,651

42,953

Services

5,592

4,725

Rental income

886

461

Others

44,756

26,975

Subtotal manufactured products and services rendered

825,868

615,851

Agricultural produce and biological assets:

Soybean

50,713

40,549

Corn

23,690

22,167

Wheat

7,251

6,583

Rice

6,925

628

Sunflower

1,956

4,190

Barley

1,896

1,977

Milk

669

1,919

Cattle

3,026

3,265

Cattle for dairy

7,274

10,212

Others

423

245

Subtotal agricultural produce and biological assets

103,823

91,735

Total revenue

929,691

707,586

(*) Includes revenue of mwh of energy and peanut produced by third parties for an amount of US$ 1.13 million and US$

0.24 million, respectively (June 30, 2025: revenue of mwh of energy produced by third parties for an amount of US$ 1.76 million).

Commitments to sell commodities at a future date

The Group entered into contracts to sell non-financial instruments, mainly, sugar, soybean and corn through sales forward contracts. Those contracts are held for purposes of delivery the non-financial instrument in accordance with the Group's expected sales. Accordingly, as the own use exception criteria are met, those contracts are not recorded as derivatives.

Notes to the Condensed Consolidated Interim Financial Statements (continued)

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Revenue (continued)

    The notional amount of these contracts is US$ 113.8 million as of June 30, 2026 (June 30, 2025: US$ 113.2 million) comprised primarily of 6,782 liters of ethanol (US$ 3.65 million), 382,200 mwh of energy (US$ 17.92 million), 176,866 tons of sugar (US$ 61.07 million), 39,992 tons of soybean (US$ 15.71 million), 66,341 tons of corn (US$ 12.21 million), and 14,000 tons of wheat (US$ 3.08 million) which expire between December 2026 and May 2027.

  2. Cost of revenue

    The following tables show our cost of revenue for the periods indicated:

    Total

    Six-month ended June 30, 2026 (unaudited)

    Sugar, Ethanol and Energy

    Fertilizers

    Food and Agriculture

    Finished goods at the beginning of 2026 (Note 18)

    61,457

    33,416

    75,372

    170,245

    Cost of production of manufactured products (Note 6)

    192,675

    154,203

    260,981

    607,859

    Purchases

    921

    25,054

    4,010

    29,985

    Agricultural produce

    11,840

    -

    116,480

    128,320

    Transfer to raw material

    -

    -

    (47,599)

    (47,599)

    Direct agricultural selling expenses

    -

    -

    10,180

    10,180

    Tax recoveries (i)

    (24,131)

    -

    -

    (24,131)

    Changes in net realizable value of agricultural produce after harvest

    636

    -

    2,128

    2,764

    Loss of idle productive capacity

    7,203

    -

    -

    7,203

    Finished goods as of June 30, 2026 (Note 18)

    (60,874)

    (85,441)

    (85,861)

    (232,176)

    Exchange differences

    2,857

    -

    9,087

    11,944

    Cost of revenue for the period

    192,584

    127,232

    344,778

    664,594

    (i): Correspond to the presumed credit of ICMS (Imposto sobre Circulação de Mercadorias e Prestação de Serviços) over the sale values.

    Six-month ended June 30, 2025 (unaudited)

    Sugar, Ethanol and Energy

    Food and Agriculture

    Total

    Finished goods at the beginning of 2025

    94,633

    93,521

    188,154

    Cost of production of manufactured products (Note 6)

    172,825

    258,284

    431,109

    Purchases

    1,999

    22,627

    24,626

    Agricultural produce

    8,356

    141,253

    149,609

    Transfer to raw material

    -

    (60,128)

    (60,128)

    Direct agricultural selling expenses

    -

    10,062

    10,062

    Tax recoveries (i)

    (23,892)

    -

    (23,892)

    Changes in net realizable value of agricultural produce after harvest

    (774)

    3,334

    2,560

    Loss of idle productive capacity

    17,912

    -

    17,912

    Finished goods as of June 30, 2025

    (29,588)

    (124,632)

    (154,220)

    Exchange differences

    6,921

    1,869

    8,790

    Cost of revenue for the period 248,392 346,190 594,582

    (i): Correspond to the presumed credit of ICMS (Imposto sobre Circulação de Mercadorias e Prestação de Serviços) over the sale values.

    Notes to the Condensed Consolidated Interim Financial Statements

    (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  3. Expenses by nature

The following table provides the additional disclosure required on the nature of expenses and their relationship to the function within the Group:

Six-month ended June 30, 2026 (unaudited)

Total

Total

Cost of production of manufactured products (Note 5)

Sugar, Ethanol and Energy

Fertilizers

Food and Agriculture

General and Administrative Expenses

Selling Expenses

Salaries, social security expenses and employee benefits

23,530

11,364

20,998

55,892

27,809

9,799

93,500

Raw materials and consumables

4,146

82,287

21,685

108,118

-

-

108,118

Depreciation and amortization

67,827

35,396

8,113

111,336

14,800

1,919

128,055

Depreciation of right-of-use assets

6,423

167

113

6,703

10,597

74

17,374

Fuel, lubricants and others

18,134

-

2,591

20,725

574

141

21,440

Maintenance and repairs

15,729

6,415

5,475

27,619

2,649

1,616

31,884

Freights

166

13,002

9,773

22,941

-

43,581

66,522

Export taxes / selling taxes

-

-

-

-

329

29,357

29,686

Export expenses

-

253

-

253

-

10,296

10,549

Contractors and services

6,147

4,242

997

11,386

4,009

2,056

17,451

Energy transmission

-

-

-

-

-

1,310

1,310

Energy power

639

-

5,098

5,737

674

124

6,535

Professional fees

323

-

195

518

5,673

424

6,615

Other taxes

2,921

-

272

3,193

166

68

3,427

Contingencies

-

-

-

-

755

-

755

Lease expense and similar arrangements

-

-

749

749

1,310

387

2,446

Third parties raw materials

7,331

-

45,731

53,062

-

-

53,062

Tax recoveries

(1,224)

-

-

(1,224)

-

-

(1,224)

Others

3,779

1,077

3,058

7,914

5,599

10,611

24,124

Subtotal

155,871

154,203

124,848

434,922

74,944

111,763

621,629

Own agricultural produce consumed

36,804

-

136,133

172,937

-

-

172,937

Total

192,675

154,203

260,981

607,859

74,944

111,763

794,566

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Expenses by nature (continued)

    Six-month ended June 30, 2025 (unaudited)

    Cost of production of manufactured

    Total

    products (Note 5) General and

    Selling

    Sugar, Ethanol and Energy

    Food and Agriculture

    Administrati ve Expenses

    Expenses Total

    Salaries, social security expenses and employee benefits

    19,061

    20,432 39,493

    28,254

    7,131

    74,878

    Raw materials and consumables

    2,118

    22,865 24,983

    -

    -

    24,983

    Depreciation and amortization

    48,754

    5,732 54,486

    13,094

    763

    68,343

    Depreciation of right-of-use assets

    5,145

    39 5,184

    10,553

    36

    15,773

    Fuel, lubricants and others

    13,256

    1,922 15,178

    481

    132

    15,791

    Maintenance and repairs

    12,488

    5,684 18,172

    3,773

    470

    22,415

    Freights

    242

    7,974 8,216

    (13)

    33,669

    41,872

    Export taxes / selling taxes

    -

    - -

    -

    18,423

    18,423

    Export expenses

    -

    - -

    -

    7,049

    7,049

    Contractors and services

    4,379

    1,822 6,201

    -

    -

    6,201

    Energy transmission

    -

    - -

    -

    982

    982

    Energy power

    451

    4,703 5,154

    336

    124

    5,614

    Professional fees

    457

    160 617

    9,162

    320

    10,099

    Other taxes

    3,922

    248 4,170

    664

    100

    4,934

    Contingencies

    -

    - -

    394

    -

    394

    Lease expense and similar arrangements

    -

    947 947

    852

    442

    2,241

    Third parties raw materials

    7,052

    46,346 53,398

    -

    -

    53,398

    Tax recoveries

    (2,270)

    - (2,270)

    -

    -

    (2,270)

    Others

    4,331

    4,019 8,350

    3,417

    7,111

    18,878

    Subtotal

    119,386

    122,893 242,279

    70,967

    76,752

    389,998

    Own agricultural produce consumed

    53,439

    135,391 188,830

    -

    -

    188,830

    Total

    172,825

    258,284 431,109

    70,967

    76,752

    578,828

    Notes to the Condensed Consolidated Interim Financial Statements

    (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  2. Salaries and social security expenses

Six-month period ended June 30, 2026 2025

(unaudited)

Wages and salaries

103,364

79,725

Social security costs

27,296

21,488

Equity-settled share-based compensation

4,154

11,894

134,814

113,107

8. Other operating income expense, net

Six-month period ended June 30,

2026

2025

(unaudited)

(Loss) / gain from commodity derivative financial instruments

(699)

3,014

Gain from disposal of other property items

1,930

408

Net (loss) / gain from fair value adjustment of Investment property

(3,538)

479

Tax credits recognized

7,758

3,419

Others

2,448

1,075

7,899 8,395

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Financial results, net

    Six-month period ended June 30, 2026 2025

    (unaudited)

    Finance income:

    - Interest income

    14,925

    4,121

    - Foreign exchange gain, net

    91,082

    34,000

    - Gain from interest rate/foreign exchange rate derivative financial instruments

    -

    4,731

    - Other income

    4,950

    505

    Finance income

    110,957

    43,357

    Finance costs:

    - Interest expense

    (72,220)

    (23,222)

    - Finance cost related to lease liabilities

    (18,410)

    (19,999)

    - Taxes

    (5,691)

    (3,199)

    - Loss from interest rate/foreign exchange rate derivative financial instruments

    (4,605)

    -

    - Other expenses

    (4,838)

    (1,228)

    Finance costs

    (105,764)

    (47,648)

    Other financial results - Net (loss) of inflation effects on the monetary items

    (13,195)

    (5,317)

    Total financial results, net

    (8,002)

    (9,608)

    Notes to the Condensed Consolidated Interim Financial Statements

    (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  2. Taxation

Taxes on income in the interim periods are recognized using the tax rate that would be applicable to expected total annual earnings.

June 30, June 30,

2026 2025

(unaudited)

Current income tax

(56,261)

(3,433)

Deferred income tax

18,777

5,372

Income tax (expense) / benefit

(37,484)

1,939

The gross movement on the deferred income tax liability is as follows:

June 30,

2026

(unaudited)

June 30,

2025

Beginning of period

(704,912)

(314,829)

Exchange differences

(39,779)

(7,400)

Effect of fair value valuation for farmlands

35,440

417

Others

(1,207)

3,138

Income tax benefit

18,777

5,372

End of period

(691,681)

(313,302)

The tax on the Group's profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:

June 30, June 30,

2026 2025

(unaudited)

Tax calculated at the tax rates applicable to profits in the respective countries

(38,045)

1,445

Non-deductible items

(456)

(345)

Non-taxable income

6,007

4,547

Tax losses where no deferred tax asset was recognized

(6,113)

-

Previously unrecognized tax losses now recouped to reduce tax expenses (1)

578

4,638

Effect of IAS 29 on Argentina's shareholder's equity and deferred income tax.

657

(5,993)

Impact of different functional and tax currencies

(899)

-

Others

787

(2,353)

Income tax (expense) / profit

(37,484)

1,939

(1) 2026 includes 578 of adjustment by inflation of tax loss carryforwards in Argentina (2,270 in 2025).

Tax Inflation Adjustment in Argentina

The information of Tax Inflation Adjustment in Argentina which is described in detail in Note 10 to annual consolidated financial statements.

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Taxation (continued)

    OECD Pillar Two model rules

    The group is within the scope of the OECD Pillar Two model rules. Pillar Two legislation was enacted in Luxembourg, the jurisdiction in which Adecoagro S.A. is incorporated, and came into effect for the fiscal year starting on January 1st, 2024.

    The group has not recognized Pillar Two current tax for the period ended June 30, 2026.

    The group applies the IAS 12 exception to recognising and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes.

    Adecoagro S.A.

    Notes to the Condensed Consolidated Interim Financial Statements

    (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  2. Property, plant and equipment, net

progress

Changes in the Group's property, plant and equipment for the six-month periods ended June 30, 2026 and 2025 were as follows:

Farmlands

Farmland improvements

Buildings and facilities

Machinery, equipment, furniture and Fittings

Bearer plants Others Work in

Total

Six-month period ended June 30 2025

Opening net book amount.

676,760

15,393

303,755

181,115

327,570

17,068

26,928

1,548,589

Exchange differences

533

(134)

6,067

20,488

45,647

(143)

1,377

73,835

Additions

-

-

4,878

24,721

65,056

2,352

27,405

124,412

Revaluation surplus

(1,485)

-

-

-

-

-

-

(1,485)

Transfers

-

-

9,033

2,769

-

(167)

(11,635)

-

Disposals

-

-

(796)

(1,048)

-

(50)

-

(1,894)

Reclassification to non-income tax credits (*)

-

-

-

(140)

-

-

-

(140)

Depreciation

-

(1,938)

(13,148)

(27,342)

(38,037)

(1,287)

-

(81,752)

Closing net book amount

675,808

13,321

309,789

200,563

400,236

17,773

44,075

1,661,565

At June 30, 2025 (unaudited)

Cost

675,808

50,977

642,090

1,192,229

1,132,569

46,479

44,075

3,784,227

Accumulated depreciation

-

(37,656)

(332,301)

(991,666)

(732,333)

(28,706)

-

(2,122,662)

Net book amount

675,808

13,321

309,789

200,563

400,236

17,773

44,075

1,661,565

Six-month period ended June 30 2026

Opening net book amount

724,879

15,680

1,498,712

194,557

414,836

25,342

136,345

3,010,351

Exchange differences

99,120

2,359

29,903

19,313

26,426

2,245

4,797

184,163

Additions

-

-

5,648

26,867

59,152

461

43,157

135,285

Revaluation surplus

(101,415)

-

-

-

-

-

-

(101,415)

Transfers

-

(3,900)

20,488

7,746

-

723

(25,057)

-

Disposals

-

-

(1,690)

(3,056)

-

(16)

-

(4,762)

Reclassification to non-income tax credits (*)

-

-

-

(88)

-

-

-

(88)

Depreciation

-

(5,344)

(49,973)

(36,764)

(43,121)

(2,158)

-

(137,360)

Closing net book amount

722,584

8,795

1,503,088

208,575

457,293

26,597

159,242

3,086,174

At June 30, 2026 (unaudited)

Cost

722,584

53,088

1,910,129

1,273,820

1,281,484

59,850

159,242

5,460,197

Accumulated depreciation

-

(44,293)

(407,041)

(1,065,245)

(824,191)

(33,253)

-

(2,374,023)

Net book amount

722,584

8,795

1,503,088

208,575

457,293

26,597

159,242

3,086,174

(*) Brazilian federal tax law allows entities to take a percentage of the total cost of the assets purchased as a tax credit. As of June 30, 2026, ICMS tax credits were reclassified to trade and other receivables.

The accompanying notes are an integral part of these condensed consolidated interim financial statements F- 26

Notes to the Condensed Consolidated Interim Financial Statements (continued)

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Property, plant and equipment, net (continued)

    The Group determined the valuation of farmlands (US$ 723 million as of June 30, 2026) using, a "Sales Comparison Approach" prepared by an independent expert. Under the Sales Comparison Approach, the Group uses sale prices of comparable properties further adjusted considering the specific aspects of each property, the most relevant premise being the price per hectare (Level 3). The Group estimated that, other factors being constant, a 10% reduction on the sales price as of June 30, 2026 would have reduced the value of the farmlands by US$ 72.3 million, which would impact, net of its tax effect, the "Revaluation surplus" item in the statement of Changes in Shareholders' Equity.

    Depreciation charges are included in "Cost of production of Biological Assets", "Cost of production of manufactured products", "General and administrative expenses", "Selling expenses", as appropriate, and/or capitalized in "Property, plant and equipment" for the six-month periods ended June 30, 2026 and 2025.

    As of June 30, 2026, borrowing costs of US$ 3,032 (June 30, 2025: US$ 2,007) were capitalized as components of the cost of acquisition or construction of qualifying assets.

  2. Right of use assets

    Changes in the Group's right of use assets for the six-month periods ended June 30, 2026 and 2025 were as follows:

    Agricultural partnership (*)

    Others Total

    (unaudited)

    As of June 30, 2025

    Opening net book amount

    352,678

    21,168

    373,846

    Exchange differences

    41,012

    3,834

    44,846

    Additions and re-measurement

    16,832

    7,419

    24,251

    Depreciation

    (32,910)

    (5,462)

    (38,372)

    Closing net book amount

    377,612

    26,959

    404,571

    As of June 30, 2026

    Opening net book amount

    355,187

    33,806

    388,993

    Exchange differences

    16,559

    9,551

    26,110

    Additions and re-measurement

    (21,596)

    559

    (21,037)

    Depreciation

    (32,179)

    (7,084)

    (39,263)

    Closing net book amount

    317,971

    36,832

    354,803

    (*) Agricultural partnerships have an average term of 6 years.

    Notes to the Condensed Consolidated Interim Financial Statements

    (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  3. Investment property

    Changes in the Group's investment property for the six-month periods ended June 30, 2026 and 2025 were as follows:

    June 30, June 30,

    2026 2025

    (unaudited)

    Beginning of period

    24,037

    33,542

    (Loss) / gain from fair value adjustment (Note 8)

    (3,538)

    479

    Exchange differences

    3,538

    (479)

    End of period

    24,037

    33,542

    Fair value

    24,037

    33,542

    Net book amount

    24,037

    33,542

    The Group determined the valuation of investment properties using a "Sales Comparison Approach" prepared by an independent expert. Sale prices of comparable properties are adjusted considering the specific aspects of each property, the most relevant premise being the price per hectare. (Level 3). The increase /decrease in the fair value is recognized in the Statement of income under the line item "Other operating income, net". There were no changes to the valuation techniques for any of the periods presented. The Group estimated that, other factors being constant, a 10% reduction on the Sales price as of June 30, 2026 would have reduced the value of the Investment properties on US$ 2.4 million, which would impact the line item "Net gain / (loss) from fair value adjustment."

    Notes to the Condensed Consolidated Interim Financial Statements

    (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  4. Intangible assets, net

    Changes in the Group's intangible assets in the six-month periods ended June 30, 2026 and 2025 were as follows:

    Goodwill

    Software

    Trademarks

    Others

    Total

    As of June 30, 2025

    Opening net book amount

    20,242

    7,162

    9,256

    571

    37,231

    Exchange differences

    236

    201

    (72)

    76

    441

    Additions

    -

    816

    2

    -

    818

    Amortization charge (i)

    -

    (822)

    (251)

    (2)

    (1,075)

    Closing net book amount

    20,478

    7,357

    8,935

    645

    37,415

    At June 30, 2025 (unaudited)

    Cost

    20,478

    20,845

    12,756

    1,261

    55,340

    Accumulated amortization

    -

    (13,488)

    (3,821)

    (616)

    (17,925)

    Net book amount

    20,478

    7,357

    8,935

    645

    37,415

    As of June 30, 2026

    Opening net book amount

    227,770

    17,179

    8,295

    631

    253,875

    Exchange differences

    2,545

    851

    1,023

    29

    4,448

    Additions

    -

    723

    -

    -

    723

    Amortization charge (i)

    -

    (1,930)

    (274)

    (2)

    (2,206)

    Closing net book amount

    230,315

    16,823

    9,044

    658

    256,840

    At June 30, 2026 (unaudited)

    Cost

    230,315

    33,752

    13,365

    1,280

    278,712

    Accumulated amortization

    -

    (16,929)

    (4,321)

    (622)

    (21,872)

    Net book amount

    230,315

    16,823

    9,044

    658

    256,840

    1. Amortization charges are included in "General and administrative expenses" and "Selling expenses" for the period ended June 30, 2026 and 2025, respectively.

      The Group conducts an impairment test annually or more frequently if events or changes in circumstances indicate that the carrying amount may not be recoverable. The last impairment test of goodwill was performed as of September 30, 2025.

      Notes to the Condensed Consolidated Interim Financial Statements

      (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  5. Biological assets

    Changes in the Group's biological assets in the six-month periods ended June 30, 2026 and 2025 were as follows:

    Sugarcane (i)

    June 30, 2026 (unaudited) Food and

    Agriculture (i) (ii)

    Total

    Beginning of year

    127,347

    187,397 314,744

    Increase due to purchases

    -

    5,978 5,978

    Initial recognition and changes in fair value of biological assets

    (7,932)

    33,423 25,491

    Decrease due to harvest / disposals

    (49,757)

    (263,184) (312,941)

    Costs incurred during the period

    70,871

    137,365 208,236

    Exchange differences

    8,577

    26,848 35,425

    End of period

    149,106

    127,827 276,933

    June 30,

    2025 (unaudited)

    Sugarcane (i)

    Food and Agriculture (i) (ii)

    Total

    Beginning of year

    69,620

    224,325

    293,945

    Increase due to purchases

    -

    2,542

    2,542

    Initial recognition and changes in fair value of biological assets

    8,712

    24,381

    33,093

    Decrease due to harvest / disposals

    (64,369)

    (317,035)

    (381,404)

    Costs incurred during the period

    61,375

    177,392

    238,767

    Exchange differences

    9,840

    (3,117)

    6,723

    End of period

    85,178

    108,488

    193,666

    1. Biological assets that are measured at fair value within level 3 of the hierarchy.

    2. Biological assets that are measured at fair value within level 2 of the hierarchy

For those biological assets measured at fair value within level 3 of the fair value hierarchy, the Group uses valuation techniques based on unobservable inputs. This is only permissible insofar as no observable market data are available. The inputs used reflect the Group's assumptions regarding the factors, which market players would consider in their pricing. The Group uses the best available information for this, including internal company data

The discounted cash flow valuation technique and the significant unobservable inputs used to calculate the fair value of these biological assets are consistent with those described in Note 16 to of the consolidated financial statements for the year ended December 31, 2025.

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

15. Biological assets (continued)

Cost of production for the six-month period ended June 30, 2026:

Sugar, Ethanol and Energy

June 30, 2026

(unaudited)

Food and Agriculture

Total

Salaries, social security expenses and employee benefits

9,255

15,214

24,469

Depreciation and amortization

2,932

-

2,932

Depreciation of right-of-use assets

17,822

-

17,822

Fertilizers, agrochemicals and seeds

24,018

12,696

36,714

Fuel, lubricants and others

3,391

2,195

5,586

Maintenance and repairs

2,726

6,320

9,046

Freights

-

3,463

3,463

Contractors and services

8,619

32,076

40,695

Feeding expenses

-

11,670

11,670

Veterinary expenses

-

2,003

2,003

Energy power

-

4,233

4,233

Professional fees

165

391

556

Other taxes

6

622

628

Lease expense and similar arrangements

616

34,579

35,195

Others

1,321

2,043

3,364

Subtotal

70,871

127,505

198,376

Own agricultural produce consumed

-

9,860

9,860

Total

70,871

137,365

208,236

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Biological assets (continued)

    Cost of production for the six-month period ended June 30, 2025:

    Sugar, Ethanol and Energy

    June 30, 2025

    (unaudited)

    Total

    Food and Agriculture

    Salaries, social security expenses and employee benefits

    7,400

    16,439

    23,839

    Depreciation and amortization

    1,615

    -

    1,615

    Depreciation of right-of-use assets

    16,637

    -

    16,637

    Fertilizers, agrochemicals and seeds

    21,774

    27,846

    49,620

    Fuel, lubricants and others

    3,018

    2,370

    5,388

    Maintenance and repairs

    2,195

    9,635

    11,830

    Freights

    -

    3,833

    3,833

    Contractors and services

    6,724

    33,886

    40,610

    Feeding expenses

    -

    12,432

    12,432

    Veterinary expenses

    -

    2,196

    2,196

    Energy power

    -

    3,782

    3,782

    Professional fees

    188

    722

    910

    Other taxes

    34

    635

    669

    Lease expense and similar arrangements

    874

    52,863

    53,737

    Others

    916

    1,792

    2,708

    Subtotal

    61,375

    168,431

    229,806

    Own agricultural produce consumed

    -

    8,961

    8,961

    Total

    61,375

    177,392

    238,767

    Biological assets as of June 30, 2026 and December 31, 2025 were as follows:

    June 30,

    2026

    December 31,

    2025

    (unaudited)

    Non-current

    Cattle for dairy production

    43,999

    39,810

    Breeding cattle

    461

    271

    Other cattle

    520

    407

    44,980

    40,488

    Current

    Breeding cattle

    20,987

    14,325

    Other cattle

    1,258

    937

    Sown land - crops

    43,776

    51,384

    Sown land - rice

    16,826

    80,263

    Sown land - sugarcane

    149,106

    127,347

    231,953

    274,256

    Total biological assets

    276,933

    314,744

    Notes to the Condensed Consolidated Interim Financial Statements

    (All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  2. Financial instruments

As of June 30, 2026, the financial instruments recognized at fair value on the statement of financial position comprise derivative financial instruments.

For Level 1 instruments, valuation is based on the unadjusted quoted prices in active markets for identical financial assets that the Group can refer to at the date of the statement of financial position. A market is deemed active if transactions take place with sufficient frequency and in sufficient quantity for price information to be available on an ongoing basis. Since a quoted price in an active market is the most reliable indicator of fair value, this should always be used if available. Level 1 financial instruments mainly consist of crop futures and options traded on the stock market. In the case of securities, the Group allocates them to this level when either a stock market price is available or prices are provided by a price quotation on the basis of actual market transactions.

Derivatives not traded on the stock market are categorized as Level 2 instruments and are valued using models based on observable market data. The Group uses inputs directly or indirectly observable in the market, other than quoted prices. If the derivative financial instrument has a fixed contract period, the inputs used for valuation must be observable for the whole of this period. Level 2 financial instruments mainly consist of interest-rate swaps and foreign-currency interest-rate swaps.

For Level 3 instruments, the Group uses valuation techniques not based on inputs observable in the market. This is only permissible insofar as no observable market data are available. The inputs used reflect the Group's assumptions regarding the factors, which market players would consider in their pricing. The Group uses the best available information for this, including internal company data. The Group does not have any Level 3 financial instruments for any of the periods presented.

There were no transfers between any levels during any of the periods presented.

The following tables present the Group's financial assets and financial liabilities that are measured at fair value as of June 30, 2026 and their allocation to the fair value hierarchy:

2026

Level 1

Level 2

Total

Assets

Derivative financial instruments

429

2,829

3,258

Short-term investment

28,044

-

28,044

Total assets

28,473

2,829

31,302

Liabilities

Derivative financial instruments

(28)

(8,027)

(8,055)

Total liabilities

(28)

(8,027)

(8,055)

The following table presents the Group's short term investment that are measured at fair value at June 30, 2026:

2026

Corporate bonds

26,390

Government securities

1,654

Short-term investment

28,044

When no quoted prices in an active market are available, fair values (particularly with derivatives) are based on recognized valuation methods. The Group uses a range of valuation models for this purpose, details of which may be obtained from the following table:

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

  1. Financial instruments (continued)

    Class

    Pricing Method

    Parameters

    Pricing Model

    Level

    Total

    Futures

    Quoted price

    -

    -

    1

    399

    Options

    Quoted price

    -

    -

    1

    (24)

    NDF

    Quoted price

    Foreign-exchange curve

    Present value method

    1

    26

    Interest-rate swaps

    Theoretical price

    Money market interest-rate curve.

    Present value method

    2

    (5,198)

    Public securities

    Quoted price

    -

    -

    1

    28,044

  2. Trade and other receivables, net

June 30,

2026

(unaudited)

December 31,

2025

Non-current

Advances to suppliers

43,273

37,183

Income tax credits

8,865

8,516

Non-income tax credits (i)

34,140

33,645

Judicial deposits

2,269

2,070

Other receivables (ii)

806

1,475

Non-current portion

89,353

82,889

Current

Trade receivables

188,979

191,635

Less: Allowance for trade receivables

(4,357)

(4,782)

Trade receivables - net

184,622

186,853

Prepaid expenses

27,620

21,014

Advance to suppliers

62,581

43,994

Income tax credits

17,358

11,847

Non-income tax credits (i)

52,603

66,961

Receivables from related parties (Note 28)

15,870

16,359

Other receivables

11,372

17,322

Subtotal

187,404

177,497

Current portion

372,026

364,350

Total trade and other receivables, net

461,379

447,239

(i) Includes US$ 88 for the six-month period ended June 30, 2026 reclassified from property, plant and equipment (for the year ended December 31, 2025: US$ 326).

Notes to the Condensed Consolidated Interim Financial Statements (continued)

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

17. Trade and other receivables, net (continued)

The fair values of current trade and other receivables approximate their respective carrying amounts due to their short-term nature. The fair values of non-current trade and other receivables approximate their carrying amount, as the impact of discounting is not significant.

The carrying amounts of the Group's trade and other receivables are denominated in the following currencies (expressed in US dollars):

June 30,

2026

December 31,

2025

(unaudited)

Currency

US Dollar

203,346

216,969

Argentine Peso

118,956

110,097

Uruguayan Peso

1,171

2,289

Brazilian Reais

137,906

117,884

461,379

447,239

As of June 30, 2026 trade receivables of US$ 34,876 (December 31, 2025: US$ 36,576) were past due but not impaired. The ageing analysis of these receivables indicates that US$ 7,468 and US$ 3,985 are over 6 months in June 30, 2026 and December 31, 2025, respectively.

The creation and release of allowance for trade receivables have been included in 'Selling expenses' in the statement of income. Amounts charged to the allowance account are generally written off, when there is no expectation of recovering additional cash.

The other classes within other receivables do not contain impaired assets.

The maximum exposure to credit risk at the reporting date is the carrying value of each class of receivable mentioned

above.

18. Inventories

June 30,

2026

December 31,

2025

(unaudited)

Raw materials

194,228

136,026

Finished goods (Note 5)

232,176

170,245

426,404

306,271

19. Cash and cash equivalents

June 30,

2026

December 31,

2025

(unaudited)

Cash at bank and on hand

105,561

202,506

Short-term bank deposits

196,902

180,644

302,463

383,150

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

20. Acquisitions (continued)

Acquisition of Profertil S.A.

On December 10, 2025, the Group acquired from Nutrien Ltd. ("Nutrien") its 50% interest in Profertil S.A. ("Profertil"). The acquisition was executed through a holding subsidiary formed together with a third-party, Asociación de Cooperativas Argentinas ("ACA"), with an 80%-20% ownership structure, respectively. The remaining 50% in Profertil was held by YPF S.A. ("YPF"). The total consideration for the transaction was US$596.3 million which were paid in cash by us and ACA on a proportionate basis. The Company incurred $3.2 million in transaction-related costs. The acquisition was accounted for under the equity method in accordance with IAS 28. Transaction costs were considered part of the cost of the investment at acquisition date.

On December 18, 2025, the Group acquired from YPF the remaining 50% interest it held in Profertil for a total consideration of US$596.3 million. The acquisition was carried out without the participation of ACA. As of June 30, 2026, it was fully paid.

The Group has accounted for the Acquisition under the purchase method of accounting in accordance with IFRS 3. Accordingly, the Group has made the allocation of the purchase price to the assets acquired and liabilities assumed based on their fair values at acquisition date. Goodwill is measured as the excess of the aggregate of consideration transferred, non controlling interest and fair value of previously held interest over the net identifiable assets acquired and liabilities assumed measured at fair value.

The approval of the Argentine Antitrust Authority is still pending.

The Company has made an allocation of the purchase price to the identifiable assets acquired and liabilities assumed based on their fair values at acquisition date. The Company has made significant assumptions and estimates in determining the purchase price, including the allocation of the purchase price in these consolidated financial statements.

The following table summarizes the fair value of purchase consideration, fair value of the previously held interest in Profertil and non controlling interest in Profertil:

Purchase consideration:

Amount paid in cash

200,000

Amounts to be paid in installments

396,282

Total purchase consideration

596,282

Fair value of previously held interest in Profertil before the business combination

476,847

Non-controlling interest

95,829

Total

1,168,958

Notes to the Condensed Consolidated Interim Financial Statements

(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)

20. Acquisitions (continued)

The following table reflects the fair value of the net assets acquired:

Cash and cash equivalents

1,007

Trade and other receivables

159,010

Short-term investments

38,688

Inventories

50,286

Right of use assets

9,221

Property, plant and equipment (*)

1,303,071

Intangible assets

10,419

Total Assets

1,571,702

Trade and other payables

(63,304)

Payroll and other liabilities

(7,039)

Borrowings

(80,151)

Lease liabilities

(9,904)

Deferred income tax liabilities

(386,344)

Current income tax liabilities

(41,462)

Provision for other liabilities

(22,744)

Total Liabilities

(610,948)

Net identifiable Assets Acquired

960,754

Add: goodwill

208,204

Net assets acquired

1,168,958

(*) Includes US$1,107 million related to the fertilizer plant complex of Bahia Blanca (Fertilizer Complex).

The Group used a depreciated replacement cost approach to measure the fair value of property, plant and equipment, including the fertilizer plant complex. Under the cost approach, the value is based on the cost of a market participant to reconstruct a substitute asset of comparable utility, adjusted for any obsolescence. The key judgment and assumptions used include the current replacement cost and physical deterioration factors, including economic useful life and effective age. As a corroborative procedure, an income approach was also performed to assess the reasonableness of the results obtained under the cost approach. Determining the fair value of property, plant and equipment requires significant management judgment and involves the use of significant estimates and assumptions. The valuation was performed with the assistance of an independent valuation specialist.

The fair value of inventory was determined based on the estimated selling price in the ordinary course of business less the estimated costs of completion and sale, and an appropriate profit margin based on the effort required to complete and sell the inventories.

The fair value of long-term debt was estimated using a discounted cash flow analysis based on current market interest rates for debt instruments with similar terms, maturity and credit risk.

All other net tangible assets were valued at their respective carrying amounts, as management believes that these amounts approximate their current fair values.

The non-controlling interest was measured at its proportionate value the NCI's proportionate share of the acquiree's identifiable net assets.

A decrease in the fair value of assets acquired, or an increase in the fair value of liabilities assumed, compared to the preliminary valuations would result in a corresponding increase in the amount of goodwill. Conversely, an increase in the fair

  1. Acquisitions (continued)

    value of identifiable assets acquired would reduce goodwill. To the extent that adjustments relate to depreciable or amortizable assets, such changes would also affect future depreciation or amortization expense.

    Goodwill is primarily attributable to expected synergies from expanding our agro-industrial platform and further diversify our revenue base. The goodwill is not deductible for tax purposes.

    Profertil has been consolidated since the acquisition date. Accordingly, the Group's consolidated statement of income for the six-month period ended June 30, 2026 includes Profertil's results of operations for the full interim period, while the consolidated statement of income for the six-month period ended June 30, 2025 does not include Profertil's results of operations. The Group reports the results of operations of the acquired business in the Fertilizers segment. See Note 3 - "Segment information" for details.

  2. Shareholder's contribution

Number of shares (thousands)

Share capital and share premium

At January 1, 2025

111,382

826,472

Reduction of issued share capital of the company

(6,000)

(9,000)

Employee share options exercised (Note 22)

-

52

Restricted shares vested

-

20,263

Purchase of own shares

-

(8,623)

Dividends to shareholders

-

(35,000)

At June 30,2025 (unaudited)

105,382

794,164

At January 1, 2026

147,872

1,097,899

Employee share options exercised (Note 22)

-

362

Restricted share vested

-

190

Dividends to shareholders

-

(35,000)

At June 30,2026 (unaudited)

147,872

1,063,451

Share capital issuance

On December 11, 2025, the Company completed a public offering of its common shares on the New York Stock Exchange. The Company issued 41,379,311 shares at a price of US$7.25 per share. In addition, on December 17, 2025, the Company issued 1,111,035 additional shares at a price of US$7.25 per share following the exercise by the underwriters of their over-allotment option. The offering resulted in aggregate gross proceeds of approximately US$308.0 million. Issuance costs related to the offering amounted to US$4.37 million.

As of June 30, 2026, the Company's issued share capital amounted to $221,808,241.50, represented by 147,872,161 shares in issue with a nominal value of US$1.50 each. Of these shares, 3,564,195 were held in treasury and 144,307,966 were outstanding as of June 30, 2026.

Decision of the Extraordinary General Shareholders' meetings

On June 6, 2025, the extraordinary general meeting of the shareholders of the Company resolved to reduce the issued share capital of the Company by US$9.0 million through the cancellation of 6,000,000 treasury shares with a nominal value of US$1.50 each. As a result, as from June 6, 2025, the Company's issued share capital amounted to US$158,072,722.50, represented by 105,381,815 shares in issue with a nominal value of US$1.50 each.

  1. Shareholder's contribution (continued) Share Repurchase Program

    On September 24, 2013, the Board of Directors of the Company has authorized a share repurchase program for up to 5% of its outstanding shares. The repurchase program has commenced on September 24, 2013 and is reviewed by the Board of Directors after each 12-month period. On December 11, 2024, the Board of Directors approved the renewal of the program, and also its extension for an additional twelve-month period, ending December 31, 2025. No further extension was approved.

    As of June 30, 2026, the Company repurchased an aggregate of 32,299,783 shares under the program, of which 11,873,388 have been utilized to cover the exercise of the Company's employee stock option plan and the granted of the restricted stock plan and 11 million shares were reduced from capital. During the six-month periods ended June 30, 2026 and 2025 the Company repurchased shares for an amount of nil and 1,057,858 respectively.

    Annual dividends

    On April 16, 2026, the Company's general shareholders' meeting approved the payment of an annual dividend of

    $35 million payable in two installments on May, 2026 and November, 2026, respectively. First installment was already paid.

    On June 17, 2025, the Company's general shareholders' meeting approved the payment of an annual dividend of

    $35 million payable in two installments in May 16, 2025 and November 19, 2025, respectively.

    Net assets

    The carrying amount of the net assets of the Company as of June 30, 2026 was USD 1.74 billions, which exceeds the Market Capitalization as of that date. This situation could mean that there is an impairment indicator as referred in IAS 36. A calculation of the value in use of net assets of the Company was made, through a discounted cash flow projections of the three major lines of business, Sugar, Ethanol and Energy, Fertilizers and Food and Agriculture based on financial forecast approved by the management covering a five-year period. The Company reached to the conclusion that no impairment should be recognized given the value in use of the Company determined is higher that its net assets book value as of June 30, 2026.

  2. Equity-settled share-based payments

    In 2004, the Group established the "2004 Incentive Option Plan" ("Option Schemes") under which the Group granted equity-settled options to senior managers and selected employees of the Group's subsidiaries.

    Further, in 2010, the Group established the "Adecoagro Restricted Share and Restricted Stock Unit Plan" (the "Restricted Share Plan") under which the Group grants restricted shares, or restricted stock units to directors of the Board, senior and medium management and key employees of the Group.

    1. Option Schemes

      No expense was accrued for both periods under the Options Schemes.

      As of June 30, 2026, 44,256 options (June 30, 2025: 5,149) were exercised. No options were forfeited or expired for any of the periods presented.

    2. Restricted Share and Restricted Stock Unit Plan

On April 1, 2025, and as a consequence of the Possible acquisition as of that date, from Tether Investment S.A. de C.V. of the controlling interest of the Company, it was decided, as specified in the plan for a circumstance like this, an acceleration of the vesting of all granted restricted shares. As of June 30, 2026, the Group recognized compensation expense of US$ 3.8 million related to the restricted shares granted under the Restricted Share Plan (June 30, 2025: US$ 14.7 million). For the six-month period ended June 30, 2026, 1,686,924 Restricted Shares were granted (June 30, 2025: 1,069,913), 24,874 were vested (June 30,

2025: 2,406,118), and nil Restricted shares were forfeited (June 30, 2025: 1,541).

Earlier from Adecoagro

All Adecoagro news releases